News › Industry News, News

Revance Announces U.S. Distribution Deal for Dermal Fillers from Teoxane SA

January 13, 2020

Revance Therapeutics, Inc., a biotechnology company searching for new innovations in neuromodulators for aesthetic and therapeutic indications, has announced the signing of a U.S. distribution agreement with Teoxane SA, making Revance the exclusive commercialization partner of the Swiss company’s Resilient Hyaluronic Acid (RHA) technology.
Read more from Revance >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • New Radiesse Research Highlights Deeper Extracellular Matrix Regeneration
    • Aesthetic Injector Academy Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Medical Purchasing Resource Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Allergan Aesthetics Launches HArmonyCa with Lidocaine in Canada
    • Designed by Stax Becomes Platinum Vendor Affiliate with the American Med Spa Association